Druggable molecular targets for the treatment of triple negative breast cancer Nakhjavani, Maryam, Hardingham, JE, Palethorpe, HM, Price, TJ and Townsend, AR 2019, Druggable molecular targets for the treatment of triple negative breast cancer, Journal of Breast Cancer, vol. 22, no. 3, pp. 341-361, doi: 10.4048/jbc.2019.22.e39. Attached Files Name Description MIMEType Size Downloads Title Druggable molecular targets for the treatment of triple negative breast cancer Author(s) Nakhjavani, Maryam Hardingham, JE Palethorpe, HM Price, TJ Townsend, AR Journal name Journal of Breast Cancer Volume number 22 Issue number 3 Start page 341 End page 361 Total pages 21 Publisher Korean Breast Cancer Society Place of publication Seoul, Republic of Korea Publication date 2019-09 ISSN 1738-6756 2092-9900 Keyword(s) BEVACIZUMAB-CONTAINING THERAPY BRCA MUTATION CHEMOTHERAPY Clinical trial CONJUGATE GLEMBATUMUMAB VEDOTIN Drug therapy FACTOR RECEPTOR INHIBITION Life Sciences & Biomedicine MESSENGER-RNA Oncology RANDOMIZED PHASE-II Science & Technology TRANSFORMING-GROWTH-FACTOR TRIAL Triple negative breast neoplasms Language eng DOI 10.4048/jbc.2019.22.e39 HERDC Research category C1 Refereed article in a scholarly journal Free to Read? Yes Persistent URL http://hdl.handle.net/10536/DRO/DU:30159015 Document type: Journal Article Collections: Faculty of Health School of Medicine Open Access Collection Related Links Link Description Link to full-text (open access)   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au. Versions Version Filter Type Mon, 22 Nov 2021, 09:33:48 EST Mon, 22 Nov 2021, 15:16:44 EST Mon, 22 Nov 2021, 15:23:12 EST Fri, 26 Nov 2021, 15:14:12 EST Sat, 04 Dec 2021, 01:48:04 EST Thu, 20 Jan 2022, 10:26:43 EST Thu, 20 Jan 2022, 11:37:47 EST Thu, 20 Jan 2022, 11:42:22 EST Filtered Full Citation counts:   Cited 29 times in TR Web of Science Cited 29 times in Scopus Search Google Scholar Access Statistics: 54 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Mon, 22 Nov 2021, 09:33:48 EST